These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25590159)

  • 1. Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis.
    Reid PA; McAllister DA; Boyd AC; Innes JA; Porteous D; Greening AP; Gray RD
    Am J Respir Crit Care Med; 2015 Jan; 191(2):233-6. PubMed ID: 25590159
    [No Abstract]   [Full Text] [Related]  

  • 2. Sputum and serum calprotectin are useful biomarkers during CF exacerbation.
    Gray RD; Imrie M; Boyd AC; Porteous D; Innes JA; Greening AP
    J Cyst Fibros; 2010 May; 9(3):193-8. PubMed ID: 20299288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z; Hartman C; Livnat G; Shteinberg M; Elenberg Y
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin--a marker of mortality in COPD? Results from a prospective cohort study.
    Holmgaard DB; Mygind LH; Titlestad I; Madsen H; Pedersen SS; Mortensen OH; Pedersen C
    COPD; 2013 Oct; 10(5):581-7. PubMed ID: 23844942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis.
    Turina MC; Sieper J; Yeremenko N; Conrad K; Haibel H; Rudwaleit M; Baeten D; Poddubnyy D
    Ann Rheum Dis; 2014 Sep; 73(9):1746-8. PubMed ID: 24845387
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations.
    Jung D; Dong K; Jang J; Lam GY; Wilcox PG; Quon BS
    J Cyst Fibros; 2021 Jan; 20(1):46-49. PubMed ID: 32475777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
    Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K
    Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis.
    Nick JA; Sanders LA; Ickes B; Briones NJ; Caceres SM; Malcolm KC; Brayshaw SJ; Chacon CS; Barboa CM; Jones MC; St Clair C; Taylor-Cousar JL; Nichols DP; Sagel SD; Strand M; Saavedra MT
    Thorax; 2013 Oct; 68(10):929-37. PubMed ID: 23783371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis.
    Smith JA; Owen EC; Jones AM; Dodd ME; Webb AK; Woodcock A
    Thorax; 2006 May; 61(5):425-9. PubMed ID: 16449266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desaturation during the 3-minute step test predicts impaired 12-month outcomes in adult patients with cystic fibrosis.
    Holland AE; Rasekaba T; Wilson JW; Button BM
    Respir Care; 2011 Aug; 56(8):1137-42. PubMed ID: 21496365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis.
    Olesen HV; Holmskov U; Schiøtz PO; Sørensen GL
    J Cyst Fibros; 2010 Jul; 9(4):257-62. PubMed ID: 20457545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.
    Szczesniak RD; McPhail GL; Duan LL; Macaluso M; Amin RS; Clancy JP
    Ann Epidemiol; 2013 Dec; 23(12):771-7. PubMed ID: 24103586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
    Wang EE; Prober CG; Manson B; Corey M; Levison H
    N Engl J Med; 1984 Dec; 311(26):1653-8. PubMed ID: 6504106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Jensen LJ; Pedersen S; Bjerre M; Mogelvang R; Jensen JS; Flyvbjerg A
    J Interv Cardiol; 2010 Apr; 23(2):123-9. PubMed ID: 20337863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of intestinal inflammation in patients with cystic fibrosis.
    Werlin SL; Benuri-Silbiger I; Kerem E; Adler SN; Goldin E; Zimmerman J; Malka N; Cohen L; Armoni S; Yatzkan-Israelit Y; Bergwerk A; Aviram M; Bentur L; Mussaffi H; Bjarnasson I; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):304-8. PubMed ID: 20512061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum retinol levels and pulmonary function in children and adolescents with cystic fibrosis.
    Woestenenk JW; Houwen RH
    J Cyst Fibros; 2016 Mar; 15(2):e16. PubMed ID: 26786700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.